Recent advances in the management of migraine.

about

Novel capsaicin-induced parameters of microcirculation in migraine patients revealed by imaging photoplethysmography.

P2860

Q55407206-0E106D2A-3388-4A44-A7CF-0678ADBB1C17

P2860

Recent advances in the management of migraine.

Item

http://www.wikidata.org/entity/Q43755979

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Recent advances in the management of migraine.

@en

Recent advances in the management of migraine.

@nl

type

Item

label

Recent advances in the management of migraine.

@en

Recent advances in the management of migraine.

@nl

prefLabel

Recent advances in the management of migraine.

@en

Recent advances in the management of migraine.

@nl

P1476

Recent advances in the management of migraine.

@en

P2093

Mark Obermann

http://www.w3.org/2001/XMLSchema#string

P2860

The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.

The cost of headache disorders in Europe: the Eurolight project.

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.

P304

2726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.9764.1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dagny Holle

P577

2016-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29098075

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

5642308

http://www.w3.org/2001/XMLSchema#string

Recent advances in the management of migraine.

about

P2860

P2860

Recent advances in the management of migraine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932